We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

Lisa Brockway

Press Release: "Multiple Sclerosis Association of America and Antidote Technologies Team Up  to Increase Awareness of Clinical Trials"

Press Release: "Improving Access To Clinical Trials: American Kidney Fund Adds User-Friendly Search Capability And Information To Kidneyfund.Org"

Applied Clinical Trials: "Antidote Incorporates Patient Centricity in Subject Enrollment"

Alzheimer's News Today: "Startups Collaborate with Galaxy in New Effort to Increase Alzheimer’s Patient Participation in Research"

Lung Cancer Alliance Announcement: "Lung Cancer Alliance Launches LungMATCH to Connect Patients to Life-Saving Treatments"

Press Release: "Digital Health Start-Ups, Roobrik and Antidote, Team Up with GALAXY to Tackle Bottleneck in Alzheimer’s Research"

Press Release: "TrialReach Rebrands as Antidote and Expands its Products to Include EHR Matching"

Fierce Biotech: "Building on Work with Lilly, Novartis and Pfizer, EHR-Trial Matching Tool Nears Market"

Business Insider: "Antidote Is a Digital Health Startup That's Aiming to Speed up the Development of Breakthrough Drugs"

Financial Times: "Ex-Google Venture Capitalist Turns up at Medtech’s TrialReach"

Evening Standard: "How Start-Up TrialReach Is Giving UK Medical Research a Much-Needed Shot in the Arm"

Press Release: "TrialReach strengthens leadership team with high ­profile hires from Shazam, Eli Lilly, Investec and TEDMED"

Press Contact
media-kit-cta